Anti-HIV antiviral activity of stavudine in a thymidine kinase-deficient cellular line. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Anti-HIV antiviral activity of stavudine in a thymidine kinase-deficient cellular line.

Antivir Ther. 1998;3(3):191-4. Unique Identifier : AIDSLINE MED/20146719
Turriziani O; Simeoni E; Dianzani F; Antonelli G; Institute of Virology, University La Sapienza, Rome, Italy.; virosap@flashnet.it


Abstract: Stavudine (d4T) is a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. It is known that stavudine is metabolized in cells to the mono-, di- and triphosphate nucleotides but the enzymes responsible for its phosphorylation are as yet unidentified. In particular, there are conflicting results concerning the role of thymidine kinase 1 (TK1) in stavudine metabolism. To gain new insights into this phenomenon we analysed the antiviral activity of stavudine in a TK1-deficient, resistant cell line. The results indicate that TK1 is responsible for the phosphorylation of stavudine but it is not the only enzyme involved in its activation. The other enzyme(s) that might be involved in the metabolism of stavudine, however, are not able to phosphorylate stavudine with the same efficiency as TK1. Since it has been shown that prolonged treatment with zidovudine may induce an in vivo defect in TK1 activity, it is tempting to speculate that patients treated for a long time with zidovudine could be resistant to further treatment with stavudine.


Keywords: JOURNAL ARTICLE Anti-HIV Agents/*PHARMACOLOGY Cell Line Human Phosphorylation Stavudine/*PHARMACOLOGY/PHARMACOKINETICS Support, Non-U.S. Gov't Thymidine Kinase/DEFICIENCY/*PHYSIOLOGYKWDjournalarticleanti-hivagents/KWDpharmacologycelllinehumanphosphorylationstavudine/KWDpharmacology/pharmacokineticssupport,non-uKWDsKWDgov'tthymidinekinase/deficiency/KWDphysiology
000530
A0052153

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .